Stabilization of aerosolizable nano-carriers by freeze-drying

Pharmaceutical Research

Volumn 26, Issue 1, 2009, Pages 129-138

  Packhaeuser, Claudia B ^a   Lahnstein, Kerstin ^b   Sitterberg, Johannes ^a   Schmehl, Thomas ^b   Gessler, Tobias ^b   Bakowsky, Udo ^a   Seeger, Werner ^b   Kissel, Thomas ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

Author keywords

Biodegradable; Freeze drying; Lyoprotectant; Nano carrier; Pulmonary delivery

Indexed keywords

NANOCARRIER; POLYMER;

AEROSOL; ARTICLE; DRUG FORMULATION; DRUG STABILITY; FREEZE DRYING; NEBULIZATION; PARTICLE SIZE; PRIORITY JOURNAL;

AEROSOLS; ARSENICALS; DRUG CARRIERS; ELECTROCHEMISTRY; EXCIPIENTS; FREEZE DRYING; LACTIC ACID; LASER-DOPPLER FLOWMETRY; MICROSCOPY, ATOMIC FORCE; NANOPARTICLES; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE; POLYGLACTIN 910; POLYGLYCOLIC ACID; POLYMERS; POLYVINYL ALCOHOL; SUSPENSIONS; VISCOSITY;

EID: 57749177461     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-008-9714-0     Document Type: Article

References (44)

1. D. A. Groneberg M. Giersig T. Welte U. Pison 2006 Nanoparticle-based diagnosis and therapy Curr. Drug Targets 7 643 648
2. D. A. Groneberg C. Witt U. Wagner K. F. Chung A. Fischer 2003 Fundamentals of pulmonary drug delivery Respir. Med. 97 382 387
3. U. Pison T. Welte M. Giersig D. A. Groneberg 2006 Nanomedicine for respiratory diseases Eur. J. Pharmacol. 533 341 350
4. M. Brzoska K. Langer C. Coester S. Loitsch T. O. Wagner C. Mallinckrodt 2004 Incorporation of biodegradable nanoparticles into human airway epithelium cells-in vitro study of the suitability as a vehicle for drug or gene delivery in pulmonary diseases Biochem. Biophys. Res. Commun. 318 562 570
5. M. Bivas-Benita S. Romeijn H. E. Junginger G. Borchard 2004 PLGA-PEI nanoparticles for gene delivery to pulmonary epithelium Eur. J. Pharm. Biopharm. 58 1 6
6. L. A. Dailey E. Kleemann M. Wittmar T. Gessler T. Schmehl C. Roberts W. Seeger T. Kissel 2003 Surfactant-free, biodegradable nanoparticles for aerosol therapy based on the branched polyesters, DEAPA-PVAL-g-PLGA Pharm. Res. 20 2011 2020
7. S. Azarmi X. Tao H. Chen Z. Wang W. H. Finlay R. Loebenberg W. H. Roa 2006 Formulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particles Int. J. Pharm. 319 155 161
8. P. G. Rogueda D. Traini 2007 The nanoscale in pulmonary delivery. Part 2: formulation platforms Expert Opin. Drug Deliv. 4 607 620
9. M. Knoch M. Keller 2005 The customised electronic nebuliser: a new category of liquid aerosol drug delivery systems Expert Opin. Drug Deliv. 2 377 390
10. P. G. Rogueda D. Traini 2007 The nanoscale in pulmonary delivery. Part 1: deposition, fate, toxicology and effects Expert Opin. Drug Deliv. 4 595 606
11. A. Zahoor S. Sharma G. K. Khuller 2005 Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosis Int. J. Antimicrob. Agents 26 298 303
12. R. Pandey A. Sharma A. Zahoor S. Sharma G. K. Khuller B. Prasad 2003 Poly (dl-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis J. Antimicrob. Chemother. 52 981 986
13. L. A. Dailey T. Schmehl T. Gessler M. Wittmar F. Grimminger W. Seeger T. Kissel 2003 Nebulization of biodegradable nanoparticles: impact of nebulizer technology and nanoparticle characteristics on aerosol features J. Contr. Rel. 86 131 144
14. G. Oberdorster 2001 Pulmonary effects of inhaled ultrafine particles Int. Arch. Occup. Environ Health 74 1 8
15. J. Fiegel J. Fu J. Hanes 2004 Poly(ether-anhydride) dry powder aerosols for sustained drug delivery in the lungs J. Contr. Rel. 96 411 423
16. A. Grenha B. Seijo C. Remunan-Lopez 2005 Microencapsulated chitosan nanoparticles for lung protein delivery Eur. J. Pharm. Sci. 25 427 437
17. M. Wittmar F. Unger T. Kissel 2006 Biodegradable brushlike branched polyesters containing a charge-modified poly(vinyl alcohol) backbone as a platform for drug delivery systems: synthesis and characterization Macromolecules 39 1417 1424
18. C. Packhaeuser, M. Wittmar, J. Sitterberg, T. Gessler, T. Schmehl, U. Bakowsky, W. Seeger, and T. Kissel. Fast-degrading nanocarriers for pulmonary drug delivery, Proceedings-33rd Annual Meeting & Exposition of the Controlled Release Society, Vol. 2006, Vienna, Austria, 2006, pp. Abstract # 341.
19. Y. I. Jeong Y. H. Shim C. Kim G. T. Lim K. C. Choi C. Yoon 2005 Effect of cryoprotectants on the reconstitution of surfactant-free nanoparticles of poly(dl-lactide-co-glycolide) J. Microencapsul. 22 593 601
20. S. Kamiya Y. Nozawa A. Miyagishima T. Kurita Y. Sadzuka T. Sonobe 2006 Physical characteristics of freeze-dried griseofulvin-lipids nanoparticles Chem. Pharm. Bull. (Tokyo) 54 181 184
21. E. Vighi B. Ruozi M. Montanari R. Battini E. Leo 2007 Re-dispersible cationic solid lipid nanoparticles (SLNs) freeze-dried without cryoprotectors: characterization and ability to bind the pEGFP-plasmid Eur. J. Pharm. Biopharm. 67 320 328
22. B. Li S. Li Y. Tan D. B. Stolz S. C. Watkins L. H. Block L. Huang 2000 Lyophilization of cationic lipid-protamine-DNA (LPD) complexes J. Pharm. Sci. 89 355 364
23. C. Brus E. Kleemann A. Aigner F. Czubayko T. Kissel 2004 Stabilization of oligonucleotide-polyethylenimine complexes by freeze-drying: physicochemical and biological characterization J. Contr. Rel. 95 119 131
24. M. Sameti G. Bohr M. N. Ravi Kumar C. Kneuer U. Bakowsky M. Nacken H. Schmidt C. M. Lehr 2003 Stabilisation by freeze-drying of cationically modified silica nanoparticles for gene delivery Int. J. Pharm. 266 51 60
25. W. Abdelwahed G. Degobert S. Stainmesse H. Fessi 2006 Freeze-drying of nanoparticles: formulation, process and storage considerations Adv. Drug Del. Rev. 58 1688 1713
26. T. Jung A. Breitenbach T. Kissel 2000 Sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide)s facilitate the preparation of small negatively charged biodegradable nanospheres J. Control. Release 67 157 169
27. R. H. Müller, and R. Schuhmann. Teilchengrößenmessung in der Laborpraxis. Wissenschaftliche Verlagsgesellschaft, Stuttgart, 1996.
28. L. A. Dailey T. Schmehl T. Gessler M. Wittmar F. Grimminger W. Seeger T. Kissel 2003 Nebulization of biodegradable nanoparticles: impact of nebulizer technology and nanoparticle characteristics on aerosol features J Control. Release 86 131 144
29. K. Imamura M. Iwai T. Ogawa T. Sakiyama K. Nakanishi 2001 Evaluation of hydration states of protein in freeze-dried amorphous sugar matrix J. Pharm. Sci. 90 1955 1963
30. A. M. Layre P. Couvreur J. Richard D. Requier N. Eddine Ghermani R. Gref 2006 Freeze-drying of composite core-shell nanoparticles Drug Dev. Ind. Pharm. 32 839 846
31. B. Lu S. B. Xiong H. Yang X. D. Yin R. B. Zhao 2006 Mitoxantrone-loaded BSA nanospheres and chitosan nanospheres for local injection against breast cancer and its lymph node metastases. I: formulation and in vitro characterization Int. J. Pharm. 307 168 174
32. C. Telang L. Yu R. Suryanarayanan 2003 Effective inhibition of mannitol crystallization in frozen solutions by sodium chloride Pharm. Res. 20 660 667
33. W. Wang 2000 Lyophilization and development of solid protein pharmaceuticals Int. J. Pharm. 203 1 60
34. X. C. Tang M. J. Pikal L. S. Taylor 2002 The effect of temperature on hydrogen bonding in crystalline and amorphous phases in dihydropyrine calcium channel blockers Pharm. Res. 19 484 490
35. M. G. Fakes M. V. Dali T. A. Haby K. R. Morris S. A. Varia A. T. M. Serajuddin 2000 Moisture sorption behavior of selected bulking agents used in lyophilized products PDA J Pharm Sci Technol. 54 144 149
36. R. W. Niven A. Y. Ip S. Mittelman S. J. Prestrelski T. Arakawa 1995 Some factors associated with the ultrasonic nebulization of proteins Pharm. Res. 12 53 59
37. H. Steckel F. Eskandar 2003 Factors affecting aerosol performance during nebulization with jet and ultrasonic nebulizers Eur. J. Pharm. Sci. 19 443 455
38. K. Kawakami K. Miyoshi N. Tamura T. Yamaguchi Y. Ida 2006 Crystallization of sucrose glass under ambient conditions: evaluation of crystallization rate and unusual melting behavior of resultant crystals J. Pharm. Sci. 95 1354 1363
39. X. M. Zeng G. P. Martin C. Marriott J. Pritchard 2000 The influence of crystallization conditions on the morphology of lactose intended for use as a carrier for dry powder aerosols J. Pharm. Pharmacol. 52 633 643
40. R. W. Niven 1995 Delivery of biotherapeutics by inhalation aerosol Crit. Rev. Ther. Drug Carrier Syst. 12 151 231
41. H.-K. Chan N. Y. K. Chew 2003 Novel alternative methods for the delivery of drugs for the treatment of asthma Adv. Drug Del. Rev. 55 793 805
42. P. Baldrick D. G. Bamford 1997 A toxicological review of lactose to support clinical administration by inhalation Food Chem. Toxicol. 35 719 733
43. J. O. Sham Y. Zhang W. H. Finlay W. H. Roa R. Lobenberg 2004 Formulation and characterization of spray-dried powders containing nanoparticles for aerosol delivery to the lung Int. J. Pharm. 269 457 467
44. R. O. Cook R. K. Pannu I. W. Kellaway 2005 Novel sustained release microspheres for pulmonary drug delivery J Control. Release 104 79 90